figshare
Browse
Table 1.xls (9.5 kB)

Baseline characteristics of study participants at completion of Cryptococcal meningitis therapy.

Download (9.5 kB)
dataset
posted on 2019-01-30, 18:42 authored by Jonathan Kitonsa, Yunia Mayanja, Emmanuel Aling, Julius Kiwanuka, Juliana Namutundu, Zacchaeus Anywaine, Abu-Baker Ggayi, Freddie Kibengo, Noah Kiwanuka, Pontiano Kaleebu

Baseline characteristics of study participants at completion of Cryptococcal meningitis therapy.

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    ISRCTNCCMtherapy2015. Survival analysisHRmortality rateFluconazole 800 mgretrospective cohort study6 monthsCIUganda Background Cryptococcal meningitisSD10 weeksHIV2 years

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC